American Capital Advisory LLC Has $402,000 Stock Position in The Cigna Group (NYSE:CI)

American Capital Advisory LLC lessened its holdings in shares of The Cigna Group (NYSE:CI) by 2.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,455 shares of the health services provider’s stock after selling 35 shares during the period. American Capital Advisory LLC’s holdings in The Cigna Group were worth $402,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of the business. AMF Tjanstepension AB raised its stake in The Cigna Group by 18.6% during the third quarter. AMF Tjanstepension AB now owns 73,600 shares of the health services provider’s stock worth $25,511,000 after buying an additional 11,550 shares during the last quarter. Atomi Financial Group Inc. raised its position in shares of The Cigna Group by 9.7% in the 3rd quarter. Atomi Financial Group Inc. now owns 1,590 shares of the health services provider’s stock worth $551,000 after acquiring an additional 140 shares in the last quarter. Brookstone Capital Management lifted its stake in shares of The Cigna Group by 3.1% in the 3rd quarter. Brookstone Capital Management now owns 1,338 shares of the health services provider’s stock valued at $464,000 after purchasing an additional 40 shares during the period. CWM LLC boosted its position in shares of The Cigna Group by 0.4% during the 3rd quarter. CWM LLC now owns 70,893 shares of the health services provider’s stock valued at $24,560,000 after purchasing an additional 298 shares in the last quarter. Finally, Wedmont Private Capital grew its stake in The Cigna Group by 2.5% during the third quarter. Wedmont Private Capital now owns 4,291 shares of the health services provider’s stock worth $1,460,000 after purchasing an additional 105 shares during the period. Institutional investors own 86.99% of the company’s stock.

The Cigna Group Trading Down 0.2 %

NYSE CI opened at $286.67 on Friday. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The business has a fifty day simple moving average of $290.87 and a 200 day simple moving average of $323.07. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83. The firm has a market capitalization of $79.74 billion, a P/E ratio of 23.42, a PEG ratio of 0.97 and a beta of 0.54.

The Cigna Group (NYSE:CI) last announced its earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter in the previous year, the company posted $6.79 earnings per share. On average, analysts predict that The Cigna Group will post 29.66 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th will be paid a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.11%. The ex-dividend date is Wednesday, March 5th. This is an increase from The Cigna Group’s previous quarterly dividend of $1.40. The Cigna Group’s payout ratio is presently 45.75%.

Analyst Upgrades and Downgrades

CI has been the topic of several recent analyst reports. Wells Fargo & Company dropped their price target on The Cigna Group from $370.00 to $341.00 and set an “equal weight” rating on the stock in a research note on Tuesday. Royal Bank of Canada dropped their target price on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a research report on Friday, November 1st. UBS Group reduced their price target on shares of The Cigna Group from $410.00 to $390.00 and set a “buy” rating for the company in a report on Monday, February 3rd. Oppenheimer dropped their price objective on shares of The Cigna Group from $400.00 to $375.00 and set an “outperform” rating on the stock in a report on Friday, January 31st. Finally, Stephens reduced their target price on The Cigna Group from $410.00 to $380.00 and set an “overweight” rating for the company in a research note on Friday, January 31st. Three analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, The Cigna Group presently has an average rating of “Moderate Buy” and a consensus target price of $373.69.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.